Skip to main content
OpenTrials

Clinical trial condition

Alzheimer's Disease

Explore clinical trials studying Alzheimer's Disease. Study availability and eligibility vary by location and protocol.

802 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Alzheimer's Disease trial results

Completed

24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease

NCT02579252

Conditions
Alzheimer Disease, Alzheimer's Disease, Behavior, +16 more
Locations
  • Ordination Dr. Bancher Horn, Lower Austria, Austria
  • Universitätsklinik für Neurologie Graz, Styria, Austria
  • Abteilung Psychiatrie und Psychotherapie, LKH Hall Hall in Tirol, Tyrol, Austria
  • Universitätsklinikum Innsbruck Innsbruck, Tyrol, Austria
View all 42 locations
View Trial Details
Completed

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

NCT01735630

Conditions
Aberrant Motor Behavior in Dementia, Aggression, Alzheimer Disease, +19 more
Locations
  • TransitionTIL Investigational Site Birmingham, Alabama, United States
  • TransitionTIL Investigational Site Phoenix, Arizona, United States
  • TransitionTIL Investigational Site Phoenix, Arizona, United States
  • TransitionTIL Investigational Site Encino, California, United States
View all 70 locations
View Trial Details
Completed

ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease

NCT00934050

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Sun Health Research Institute Sun City, Arizona, United States
  • University of Arizona, Health Sciences Center, Dept. of Neurology Tucson, Arizona, United States
  • Margolin Brain Institute Fresno, California, United States
View all 38 locations
View Trial Details
Completed

A Safety Study of LY2886721 Single Doses in Healthy Subjects

NCT01133405

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States
View Trial Details
Completed

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

NCT02167256

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Banner Sun Health Research Institute Sun City, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Yale Alzheimer's Disease Research Unit New Haven, Connecticut, United States
View all 22 locations
View Trial Details

Related conditions